Lineage Cell Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Lineage Cell Therapeutics using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Sep 2024 | 2024-11-14 | $-0.02 | $-0.03 | 33.3 % |
Jun 2024 | 2024-08-08 | $-0.03 | $-0.04 | 25.0 % |
Mar 2024 | 2024-05-09 | $-0.04 | $-0.04 | 0.00 % |
Dec 2023 | 2024-03-07 | $-0.03 | $-0.04 | 25.0 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Sep 2024 | 2024-11-14 | $3.78M | $886.57K | 326.3 % |
Jun 2024 | 2024-08-08 | $1.41M | $970.00K | 45.1 % |
Mar 2024 | 2024-05-09 | $1.44M | $1.36M | 6.18 % |
Dec 2023 | 2024-03-07 | $2.10M | $1.31M | 60.3 % |
Lineage Cell Therapeutics ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 14, 2024 for Q3.
Lineage Cell Therapeutics ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 14, 2024 for Q3 and the Actual EPS was $-0.02, which beat the estimate of $-0.03.
Lineage Cell Therapeutics ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 14, 2024 for Q3 and the Actual EPS was {{actualEPS}}, which beat the estimate of {{estEPS}}.
Browse earnings estimates, EPS, and revenue on all stocks.